Comparing Dabigatran vs Xarelto
| Dabigatran | Xarelto (rivaroxaban) |
|
|---|
| Dabigatran | Xarelto (rivaroxaban) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Prevention of Thromboembolism in Atrial Fibrillation, Deep Vein Thrombosis - Prophylaxis, Pulmonary Embolism, Deep Vein Thrombosis, Deep Vein Thrombosis/Pulmonary Embolism Prophylaxis... View more |
Prescription only
Xarelto (rivaroxaban) is an oral anticoagulant used to treat deep vein thrombosis and pulmonary embolism, and for preventing blood clots and reducing cardiovascular risks across multiple conditions... View more |
Related suggestions Prevention of Thromboembolism in Atrial Fibrillation
Deep Vein Thrombosis
Deep Vein Thrombosis, Prophylaxis
|
|||||||||||||||
| More about Dabigatran | More about Xarelto (rivaroxaban) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Dabigatran has an average rating of 6.9 out of 10 from a total of 102 ratings on Drugs.com. 51% of reviewers reported a positive effect, while 13% reported a negative effect. |
Xarelto has an average rating of 5.4 out of 10 from a total of 227 ratings on Drugs.com. 37% of reviewers reported a positive effect, while 42% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Dabigatran side effects |
View all Xarelto side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Dabigatran prices |
View all Xarelto prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Pradaxa |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
17 hours |
13 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 306 drugs are known to interact with Dabigatran:
|
A total of 391 drugs are known to interact with Xarelto:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
October 19, 2010 |
N/A |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
|
|||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.